Back to Screener

Healthcare

Xilio Therapeutics, Inc.(XLO)

Live Price

Offline

$8.79

+0.46% today

1Y Change

-11.41%

Window

Jun 23, 2025 โ†’ Jun 12, 2026

Market Cap
$50.00M
Revenue Growth
+589.9%
EPS Growth
+72.5%
Dividend Yield
0.0%

Coverage: 245 bars ยท Jun 23, 2025 โ†’ Jun 12, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Xilio Therapeutics, Inc. (XLO) is a Healthcare stock with a market cap of $50.00M and listed on NASDAQ. The stock last traded around $8.79 and down 11.4% across the available one-year price window (Jun 23, 2025 โ†’ Jun 12, 2026). Baseline metrics include revenue growth of +589.9%, EPS growth of +72.5%, a dividend yield of 0.0%. What stands out right now is revenue +589.9%, EPS +72.5%, free cash flow +70.1% with operating margin -95.9% and ROIC -42.1%. Valuation is more restrained than many high-expectation growth names at price/sales 1.1. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines XLO price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Comparison

Normalized Performance vs SPY

Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.

1Y shared range

XLO

โ€”

Normalized return

SPY

โ€”

S&P 500

Excess Return

โ€”

Relative to SPY

XLO Max Drawdown

-40.90%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for XLO and SPY.

Calendar-year return history is still loading or unavailable.

Earnings Reports

๐Ÿ“… Next earningsAug 13, 2026
PeriodB/MEPSEPS ฮ”RevenueRev ฮ”Report
โ€”
Aug 13, 26
TBD
โ€”
Est -0.58
โ€”
โ€”
Est 12720.0B
โ€”
Aug 13
โ€”
May 12, 26
โœ“
-0.58
Est -0.66
+12.1%
12650.0B
Est 8520.0B
+48.5%
May 12
โ€”
Mar 23, 26
โœ“
-0.85
Est -1.68
+49.4%
13690.0B
Est 10900.0B
+25.6%
Mar 23
โ€”
Nov 13, 25
โœ“
-0.03
Est -0.45
+93.3%
19066.0B
Est 18635.0B
+2.3%
Nov 13
โ€”
Aug 14, 25
โœ“
-0.16
Est -1.10
+85.5%
8084.0B
Est 18635.0B
-56.6%
Aug 14
โ€”
May 8, 25
โœ“
-0.18
Est -2.70
+93.3%
2930.0B
Est 23200.0B
-87.4%
May 8
โ€”
Mar 11, 25
โœ“
-0.20
Est -3.03
+93.4%
1724.0B
Est 23200.0B
-92.6%
Mar 11
โ€”
Nov 7, 24
โœ“
-0.22
Est -0.25
+12.0%
2263.0B
Est 3300.0B
-31.4%
Nov 7
โ€”
Aug 8, 24
โœ—
-0.24
Est -0.23
-4.3%
2357.0B
Est 30000.0B
-92.1%
Aug 8
โ€”
May 14, 24
โœ—
-0.62
Est -0.11
-463.6%
โ€”
Est 30000.0B
โ€”
May 14
โ€”
Apr 1, 24
โ€”
-0.64
Est -0.64
0.0%
โ€”
Est 30000.0B
โ€”
Apr 1
โ€”
Nov 9, 23
โœ“
-0.61
Est -0.81
+24.7%
โ€”
Est โ€”
โ€”
Nov 9
โ€”
Aug 14, 23
โœ“
-0.70
Est -0.87
+19.5%
โ€”
Est โ€”
โ€”
Aug 14
โ€”
May 9, 23
โœ“
-0.83
Est -0.89
+6.7%
โ€”
Est โ€”
โ€”
May 9
โ€”
Mar 2, 23
โœ—
-0.82
Est -0.78
-5.1%
โ€”
Est โ€”
โ€”
Mar 2
โ€”
Nov 9, 22
โœ“
-0.72
Est -0.88
+18.2%
โ€”
Est โ€”
โ€”
Nov 9
โ€”
Aug 9, 22
โœ—
-0.90
Est -0.78
-15.4%
โ€”
Est โ€”
โ€”
Aug 9
โ€”
May 12, 22
โœ“
-0.78
Est -0.93
+16.1%
โ€”
Est โ€”
โ€”
May 12
โ€”
Mar 1, 22
โœ“
-0.98
Est -1.17
+16.2%
โ€”
Est โ€”
โ€”
Mar 1
โ€”
Dec 2, 21
โœ—
-21.27
Est -1.60
-1229.4%
โ€”
Est โ€”
โ€”
Dec 2
โ€”
Jun 30, 21
-0.87
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
Jun 30
โ€”
Mar 31, 21
-0.63
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
Mar 31
โ€”
Dec 31, 20
-0.78
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
Dec 31
โ€”
Sep 30, 20
-0.56
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
Sep 30
โ€”
Jun 30, 20
-27.98
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
Jun 30
โ€”
Mar 31, 20
-19.83
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
Mar 31
No upcoming earnings in the next 90 days

Next Step

Connect reports to catalysts

Earnings pages get much more useful when they are tied back to upcoming dates, expectations, and peer setups.

Read the earnings calendar guideOpen the calendar screener